Rhythm Pharmaceuticals, Inc.
RYTM· Nasdaq
Released Nov 14, 2017, before the open
10-Q filed Nov 14, 2017, 45 days after period end · 0001558370-17-008882
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 |
|---|---|---|
| Net Income | -$10.02M | -$6.39M |
| EPS Diluted | -$1.78 | -$0.71 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rhythm Pharmaceuticals, Inc. · CIK 1649904 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 14, 2017 · 45 d after period end